Trade Apellis Pharmaceuticals, Inc. - APLS CFD

Trading Conditions

• Type: CFD
• Spread: 0.13
• Long position overnight funding adjustment: -0.02171%
• Short position overnight funding adjustment: -0.00052%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 1
• Margin: 50.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premium: 1%

Key Stats

• Prev. Close: 18.76
• Open: 18.28
• 1-Year Change: -27.06%
• Day's Range: 17.85 - 18.28

What is Apellis Pharmaceuticals, Inc. (APLS)?

Apellis Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development of novel therapies targeting the complement system, a part of the immune response implicated in various diseases. The company’s research and development efforts concentrate on treatments for rare and serious conditions, including those affecting the eye and blood. Apellis employs advanced technologies to design drugs that modulate complement activity, aiming to address unmet medical needs. The company’s pipeline includes multiple clinical-stage candidates, and it collaborates with research institutions and partners to advance its therapeutic programs.

Apellis Pharmaceuticals, Inc. Stock Price Today: Live Overview

The price today is shaped by market transactions, with Apellis Pharmaceuticals, Inc. at $17.93. The stock’s intraday movement varies between $17.87 and $18.41, corresponding to a daily change of -4.2621%.

FAQ: Apellis Pharmaceuticals, Inc. (APLS)

What is the current price of APLS stock?

The current price stands at $17.93.

Does APLS pay dividends?

Apellis Pharmaceuticals, Inc. does not currently pay dividends.

Does APLS have a formal corporate presence or regional headquarters in the UAE?

Apellis Pharmaceuticals, Inc. operates in the UAE solely through partners and distributors without an official office or subsidiary.

What is APLS best known for?

Apellis Pharmaceuticals, Inc. is most famous for developing complement system inhibitors for rare diseases.

What assets are typically shown together with APLS?

Commonly shown alongside APLS: Teva Pharma Ind Adr Rep 1, Emergent BioSolutions, Jazz Pharma